Health Centres - Exelon
How does it work?
Exelon capsules and oral solution both contain the active ingredient rivastigmine, which is a type of medicine called an acetylcholinesterase inhibitor. It works by slowing the breakdown of a compound in the brain called acetylcholine.
Acetylcholine is a natural compound known as a neurotransmitter. Neurotransmitters are stored in nerve cells in the brain and nervous system, and are involved in transmitting messages between the nerve cells. They are necessary for the normal functioning of the brain and nervous system. Acetylcholine in the brain is continually being released by nerve cells, and then broken down by another natural chemical called acetylcholinesterase.
One of the features of both Alzheimer's disease and Parkinson's disease appears to be a lower than normal level of acetylcholine in the brain. This is due in part to degeneration of brain cells, in particular those that normally release acetylcholine.
Rivastigmine increases the level of acetylcholine in the brain. It does this by preventing the action of acetylcholinesterase, the compound which normally breaks it down. This slows the breakdown of acetylcholine that is released from remaining undamaged nerve cells in the brain.
The result of this is increased activity of acetylcholine in the brain. This improves the cognitive processes of thinking, learning and memory, and improves the symptoms of dementia and daily functioning in Alzheimer's disease.
Rivastigmine is used to treat mild to moderately severe dementia in people with Alzheimer's disease or Parkinson's disease. However, it only slows the worsening of the dementia, rather than being a cure. If the medicine has not slowed the worsening of symptoms after three months of treatment at the maintenance dose, it should be stopped. For patients who continue treatment, the benefit of the medicine should be reassessed on a regular basis and stopped when it is considered that the medicine is no longer providing a beneficial effect.
What is it used for?
- Mild to moderately severe Alzheimer's dementia
- Mild to moderately severe dementia in people with Parkinson's disease
Warning!
- A doctor will only prescribe this medicine if the patient has a caregiver available who will regularly make sure that the patient is taking the medicine.
- When starting treatment with this medicine the dose will be increased gradually to reduce the chances of side effects. Follow the instructions given by the doctor.
- If unwanted effects are experienced during treatment with the medicine, for example nausea, vomiting, abdominal pain, loss of appetite, weight loss, hallucinations, or worsening of tremor or other movement problems in people with Parkinson's disease, particularly if these occur after any dose increases, you should tell your doctor.

